| dc.contributor.author | A. Machlaurin | |
| dc.contributor.author | Satibi | |
| dc.contributor.author | N.M. Yasin | |
| dc.date.accessioned | 2014-08-07T01:00:42Z | |
| dc.date.available | 2014-08-07T01:00:42Z | |
| dc.date.issued | 2014-08-07 | |
| dc.identifier.isbn | 978-979-796-291-3 | |
| dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/58725 | |
| dc.description | PROCEEDING The International Conference Pharmaceutical Care "New Development of Pharmaceutical Care In a Pharmacogenetic and Pharmacogenomic Approach" University of Muhammadiyah Malang, April 19th 2014 | en_US |
| dc.description.abstract | Background : One of the most important treatment in pneumonia is antibiotic. Wide variations in antimicrobial prescribing practices exist in hospitalized pneumonia. Choice of first-line empiric treatment of pneumonia is still being debated.
Objective : The objective of this study was to compare the effectiveness between ceftriaxone i.v monotherapy (CTX) vs combination therapy of ceftriaxone i.v plus ciprofloxacin i.v (CTXCP) as empiric treatment in patients with hospitalized pneumonia. | en_US |
| dc.language.iso | other | en_US |
| dc.subject | hospitalized pneumonia, effectiveness, ceftriaxone i.v, ciprofloxacin i.v | en_US |
| dc.title | EFFECTIVENESS COMPARATION OF INTRAVENOUS CEFTRIAXONE MONOTHERAPY VS INTRAVENOUS CEFTRIAXONE PLUS CIPROFLOXACIN COMBINATION IN HOSPITALIZED PNEUMONIA | en_US |
| dc.type | Article | en_US |
